MedTrace Logo

Calmer Life: Testing the Effectiveness of a Treatment for Anxiety

NCT01702220 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-01-12

No results posted yet for this study

Summary

The overall goals of the proposed research study are to: (1) examine quantitative outcomes in a well-conducted randomized clinical trial of Calmer Life, relative to Enhanced Community Care, an information and referral intervention that represents care in a real-world community-service environment, and (2) evaluate implementation feasibility, which includes training community providers; examining program reach, engagement, acceptability, and barriers-facilitators; and preparing practical tools for replicating the program.

Conditions

  • Generalized Anxiety Disorder
  • Anxiety Disorder NOS

Interventions

BEHAVIORAL

CBT

6-12 sessions of CBT in person or over the phone

OTHER

ECC

6 biweekly sessions of ECC over the telephone

Sponsors & Collaborators

  • Retirement Research Foundation

    collaborator OTHER

  • Archstone Foundation

    collaborator OTHER

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Melinda A Stanley, PhD · Baylor College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2015-02-28
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01702220 on ClinicalTrials.gov